Tresiba (insulin degludec) is a long-acting insulin that lowers blood glucose levels for adults with either type 1 or type 2 diabetes mellitus. It begins to start working several hours after injection and continues to work evenly for up to 24 hours.

Insulin degludec is an ultra-long-acting basal insulin analog that was developed by Novo Nordisk under the brand name Tresiba. This modified insulin is different than human insulin by one amino acid.

Tresiba is available in two forms: single multi-dose vial or single-patient-use FlexTouch pen.

When using insulin you should be aware of symptoms of low blood sugar (hypoglycemia). Symptoms include: irritability, hunger, confusion, dizziness, anxiety or shakiness. Treat hypoglycemia by eating a sugary snack or beverage such as jelly beans, hard candies, raisins, crackers, juice or non-diet soda.

Showing all 2 results